Sort
15,440 grants matching “organoids”
Deriving correlates of protection from influenza-specific antibody and T cell receptor analysis.
$780,362Scott Dexter Boyd · Stanford University · U19 · FY2020 · AI
Broad spectrum inhibitors of paramyxovirus envelope proteins
$780,280Anne Moscona · Columbia University Health Sciences · R01 · FY2024 · AI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells
$780,235Tariq M Rana · University Of California, San Diego · R01 · FY2019 · DA
Targeting proteostatic mechanisms to inhibit LRRK2-mediated neurodegeneration and neuropathology
$780,220Annie E Hiniker · University Of Southern California · R01 · FY2024 · NS
Fibroblast Heterogeneity in Pancreatic Cancer
$780,205David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2023 · CA
Allelic Expression Imbalance in Trisomy 21
$780,000Mathew J Thayer · Oregon Health & Science University · RF1 · FY2025 · NS
Targeting alternative splicing for TCR discovery in small cell carcinomas
$779,998Owen N Witte · University Of California Los Angeles · U01 · FY2019 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas
$779,998Owen N Witte · University Of California Los Angeles · U01 · FY2022 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas
$779,998Owen N Witte · University Of California Los Angeles · U01 · FY2018 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas
$779,998Owen N Witte · University Of California Los Angeles · U01 · FY2020 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas
$779,998Owen N Witte · University Of California Los Angeles · U01 · FY2021 · CA
Fibroblast Heterogeneity in Pancreatic Cancer
$779,963David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2022 · CA
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$779,425Shirit Einav · Stanford University · R01 · FY2021 · AI
SOAT1 as a targetable dependency in Pancreatic Adenocarcinoma
$778,873David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$778,382Katerina Abigail Politi · Yale University · U01 · FY2021 · CA
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2022 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Benjamin Solomon Freedman · University Of Washington · UH3 · FY2024 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2023 · TR
Data Management Analysis and Resources Dissemination Core
$778,169William James Salerno · Baylor College Of Medicine · U19 · FY2021 · AI
Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion.
$777,691Suzanne Devkota · Cedars-Sinai Medical Center · DP1 · FY2025 · DK
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
$777,503Peng Jin · Emory University · R01 · FY2022 · AG
Mechanisms of resistance to treatment in aggressive prostate cancers
$777,497Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Type III interferon Control of Mucosal Immunity
$777,421Ivan Zanoni · Boston Children'S Hospital · R01 · FY2023 · DK
Type III interferon Control of Mucosal Immunity
$777,421Ivan Zanoni · Boston Children'S Hospital · R01 · FY2025 · DK
Measurement and Prediction of Endothelial Cross-family Signaling
$777,371Princess Izevbua Imoukhuede · University Of Washington · R01 · FY2022 · HL